PANACUR® (fenbendazole) POWERPAC
INTERNAL PARASITICIDE/DEWORMER
Product Description
PANACUR (fenbendazole) Paste 10% is indicated for the control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum), and arteritis caused by fourth stage larvae of Strongylus vulgaris in horses. PANACUR (fenbendazole) Paste 10% Equine Dewormer is supplied in 57 gram, 5 per carton, syringes.
- Proven Safe – Safe for foals, pregnant mares and older horses
- Works on a wide variety of parasites – Labeled for the control of large and small strongyles (including migrating larvae), pinworms and ascarids (roundworms)
- Effective on encysted small strongyles – A larvicidal dose is the only FDA-approved treatment for all stages of encysted small strongyles
- Reliable protection for foals – Widely recognized as the product of choice for treating ascarids in young horses
- Combat resistance – May be effective even in the face of prior fenbendazole resistance when used as part of a strategically designed anthelmintic program
- Unique Mode of Action – The antiparasitic action of PANACUR (fenbendazole) POWERPAC is due to the inhibition of energy metabolism in the parasite
| Pkg Size | UPC # | UIN # |
|---|---|---|
| 5×57 gm syringe | 021784471572 | 114001 |
Images
Advertising
Collateral
Merchandising
Contact us at RetailTeam@merck.com for merchandising program details and availability.
Social Media
Training Tools
Videos
POWERPAC® Mode of Action
POWERPAC® Mode of Action
dOWNLOADImportant Safety Information
Consult your veterinarian for the diagnosis, treatment and control of parasitism. Do not use in horses intended for human consumption.
Get the Latest Updates!
Sign up for our newsletter and stay up to date on the latest retail updates.
Sign Up Now
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global